Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASTCNASDAQ:AXDXNASDAQ:BNGONASDAQ:TLIS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTCAstrotech$5.69-3.2%$5.84$5.39▼$12.29$9.96M0.2515,072 shs106,504 shsAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22519,657 shs53.64 million shsBNGOBionano Genomics$3.29-2.7%$3.75$2.68▼$44.94$11.37M2.27109,911 shs191,875 shsTLISTalis Biomedical$1.43$1.51$1.04▼$9.35$2.61M1.32,744 shs15 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTCAstrotech-3.23%-5.01%-2.65%-12.86%-37.68%AXDXAccelerate Diagnostics0.00%0.00%0.00%-94.21%-96.54%BNGOBionano Genomics-2.66%-0.90%-12.73%+13.45%-91.60%TLISTalis Biomedical0.00%-18.29%-4.67%-17.82%-83.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTCAstrotech0.889 of 5 stars0.03.00.00.03.30.80.6AXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ABNGOBionano Genomics1.2507 of 5 stars3.11.00.00.02.00.00.6TLISTalis Biomedical0.1846 of 5 stars0.01.00.00.00.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTCAstrotech 0.00N/AN/AN/AAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ABNGOBionano Genomics 2.25Hold$7.00112.77% UpsideTLISTalis Biomedical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TLIS, BNGO, ASTC, and AXDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025BNGOBionano GenomicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.004/2/2025BNGOBionano GenomicsScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$1.00 ➝ $4.00(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTCAstrotech$1.66M5.79N/AN/A$20.45 per share0.28AXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00BNGOBionano Genomics$30.78M0.36N/AN/A$18.12 per share0.18TLISTalis Biomedical$300K8.69N/AN/A$37.95 per share0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTCAstrotech-$11.67M-$8.42N/A∞N/A-1,536.99%-46.37%-42.51%N/AAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ABNGOBionano Genomics-$112.02M-$138.92N/A∞N/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)TLISTalis Biomedical-$62.01M-$28.02N/A∞N/AN/A-79.74%-57.16%8/18/2025 (Estimated)Latest TLIS, BNGO, ASTC, and AXDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BNGOBionano Genomics-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million5/13/2025Q3 2025ASTCAstrotechN/A-$2.18N/A-$2.18N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTCAstrotechN/AN/AN/AN/AN/AAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ABNGOBionano GenomicsN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTCAstrotechN/A9.868.76AXDXAccelerate DiagnosticsN/A1.501.34BNGOBionano Genomics0.071.701.34TLISTalis BiomedicalN/A7.767.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTCAstrotech24.35%AXDXAccelerate Diagnostics17.14%BNGOBionano Genomics11.35%TLISTalis Biomedical43.77%Insider OwnershipCompanyInsider OwnershipASTCAstrotech14.90%AXDXAccelerate Diagnostics43.60%BNGOBionano Genomics0.90%TLISTalis Biomedical46.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTCAstrotech101.69 million1.44 millionNot OptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableBNGOBionano Genomics3003.36 million3.33 millionOptionableTLISTalis Biomedical2601.82 million984,000No DataTLIS, BNGO, ASTC, and AXDX HeadlinesRecent News About These CompaniesTalis Biomedical (NASDAQ:TLIS) Stock Price Down 18.3% - Here's What HappenedJune 26 at 2:59 AM | americanbankingnews.comBaker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical CorpOctober 10, 2024 | finance.yahoo.comTalis Biomedical Agrees to Settle Investor Suit for $33 MillionOctober 3, 2024 | news.bloomberglaw.comNTalis Biomedical Corp Ordinary SharesSeptember 17, 2024 | morningstar.comMInsider Buying: Talis Biomedical Co. (NASDAQ:TLIS) Major Shareholder Buys 13,167 Shares of StockAugust 29, 2024 | insidertrades.comTalis Biomedical Shares Fall on Bankruptcy Filing, Delisting NoticeAugust 24, 2024 | marketwatch.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024August 19, 2024 | investorplace.comTalis Biomedical Shares Tumble Premarket as Company Mulls BankruptcyAugust 7, 2024 | marketwatch.comWhy Talis Biomedical (TLIS) Stock Is Getting Obliterated TodayAugust 7, 2024 | benzinga.comWhy Is Talis Biomedical (TLIS) Stock Down 52% Today?August 7, 2024 | investorplace.com(TLIS) Trading ReportJuly 25, 2024 | news.stocktradersdaily.comNTalis Biomedical Corp (TLIS)May 10, 2024 | investing.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024May 8, 2024 | investorplace.comBragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and ...April 27, 2024 | eagletribune.comETalis Biomedical Corporation (TLIS)March 31, 2024 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 16, 2024 | markets.businessinsider.comTLIS Feb 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | bizjournals.comTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | finanznachrichten.deLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTLIS, BNGO, ASTC, and AXDX Company DescriptionsAstrotech NASDAQ:ASTC$5.69 -0.19 (-3.23%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$5.98 +0.29 (+5.10%) As of 06/26/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.Accelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Bionano Genomics NASDAQ:BNGO$3.29 -0.09 (-2.66%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$3.36 +0.07 (+2.13%) As of 06/26/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Talis Biomedical NASDAQ:TLIS$1.43 0.00 (0.00%) As of 06/25/2025Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
